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Abstract
Objective
The aim of this study was to estimate the heritability (h2) and genetic correlation (ρG)
between GERD symptoms severity, metabolic syndrome components, and inflammation
markers in Mexican families.
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Cross-sectional study which included 32 extended families resident in Mexico City. GERD
symptoms severity was assessed by the ReQuest in Practice questionnaire. Heritability and
genetic correlation were determined using the Sequential Oligogenic Linkage Analysis Routines software.
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Results
585 subjects were included, the mean age was 42 (±16.7) years, 57% were women. The
heritability of the severity of some GERD symptoms was h2 = 0.27, 0.27, 0.37, and 0.34
(p-value <1.0x10-5) for acidity complaints, lower abdominal complaints, sleep disturbances,
and total ReQuest score, respectively. Heritability of metabolic syndrome components ranged from 0.40 for fasting plasma glucose to 0.61 for body mass index and diabetes mellitus.
The heritability for fibrinogen and C-reactive protein was 0.64 and 0.38, respectively. Statistically significant genetic correlations were found between acidity complaints and fasting
plasma glucose (ρG = 0.40); sleep disturbances and fasting plasma glucose (ρG = 0.36);
acidity complaints and diabetes mellitus (ρG = 0.49) and between total ReQuest score and
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fasting plasma glucose (ρG = 0.43). The rest of metabolic syndrome components did not
correlate with GERD symptoms.

Conclusion
Genetic factors substantially explain the phenotypic variance of the severity of some GERD
symptoms, metabolic syndrome components and inflammation markers. Observed genetic
correlations suggest that these phenotypes share common genes. These findings suggest
conducting further investigation, as the determination of a linkage analysis in order to identify regions of susceptibility for developing of GERD and metabolic syndrome.

Introduction
Gastroesophageal Reflux Disease (GERD) and obesity are two of the most common diseases in
Western countries. The prevalence of both entities has rapidly increased, which represents a
public health problem that involves further analysis. It is estimated that between 20 to 40% of
the population in these countries has one or more symptomatic episodes of GERD at least
once a month [1–5]. In Mexico, most studies have found consistent figures with those found
in other countries, noting that at least one third of the analyzed population has complains of
heartburn at least once a month (35–44%) [6,7]. The prevalence of obesity (body mass index,
BMI30 kg/m2) in American population was 33% in 2008 [8]. In Mexico, the prevalence of
obesity according to the National Health and Nutrition Survey 2012 was 32% in people over
20 years of age [9].
The relationship between GERD symptoms and obesity remains controversial. However,
the results of recent meta-analysis reveal a strong relationship between obesity and GERD
[10]. Recently, it has been suggested that abdominal obesity might be an important risk factor
for the development of GERD symptoms more than obesity expressed as a high body mass
index [11]. Some researchers have formulated the hypothesis that the association between obesity and GERD symptoms, might be due to a physical mechanism because obesity increases
the intra-abdominal pressure, leading to an increase in intragastric pressure and consequently,
an increase in gradient of gastroesophageal pressure, inducing relaxation of the lower esophageal sphincter [12].
Besides obesity, some studies have suggested an association between gastroesophageal
reflux disease and other metabolic syndrome (MS) components, which is defined as a cluster
of metabolic disorders such as abdominal obesity, hypertension, hypertriglyceridemia, insulin
resistance, hyperglycemia, and low HDL cholesterol concentration [13]. A positive association
has been found between the waist circumference (WC) and GERD symptoms [14,15], between
hypertension and erosive esophagitis [16,17], between triglyceride concentration and non-erosive GERD [18], between insulin resistance and erosive esophagitis [17,19] and with GERD
symptoms scores [17], between hyperglycemia and reflux esophagitis [16] and with GERD
symptoms [15], between diabetes mellitus (DM) and abnormal gastroesophageal reflux measured by a 24-hour pH monitoring [20], between MS according to the International Diabetes
Federation (IDF) and GERD symptoms [15,17] and with erosive esophagitis [17,19]. Furthermore, a negative association has been found between HDL cholesterol concentration and
GERD symptoms scores [14].
Several factors have been identified for the predisposition to develop GERD, such as genetic
factors [21,22] that determine the variability in the behavior of gastrointestinal physiology of
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the upper digestive tract. Some studies have estimated the heritability (h2 defined as the proportion of the phenotypic variance attributed to genetic factors) for both GERD symptoms
and MS components, but even though recent researches suggest an association between these
two entities, there are no studies analyzing the presence of common genetic factors that could
share both phenotypes, i.e., a genetic correlation (ρG) defined as the proportion of the covariance of two phenotypes explained by common genetic factors.
Some studies [21,22] conducted in monozygotic and dizygotic twins, analyzed the heritability of GERD symptoms (heartburn and acid regurgitation), finding that genetic factors considerably contribute to the presence of these symptoms (h2 between 0.31 and 0.43). Moreover,
other studies [23–28], mostly conducted in families, have estimated the heritability of MS components, finding that a significant proportion of the variability of these phenotypes is explained
for genetic factors (h2 between 0.25 and 0.9).
The aim of this research was to estimate the heritability of GERD symptom severity, MS
components, and inflammation markers, and assess whether these phenotypes share common
genes through of genetic correlations (bivariate polygenic equations) in a sample of Mexican
families living in Mexico City. This study is the first report of heritability and genetic correlation between GERD symptoms severity and MS components for this population.

Materials and methods
Design, study population, and enrollment
Cross-sectional study, in which pamphlets and posters were delivered and posted at universities and public places in Mexico City inviting to participate in this project. This study included
32 extended families living in Mexico City consisting of at least 13 members each, over 18
years of age. The families were selected from a convenience sample and due to the high prevalence of GERD symptoms and MS components in Mexico, no proband or other criteria were
considered for inclusion. Potential participants were invited to attend a tertiary level hospital
(General Hospital of Mexico “Dr. Eduardo Liceaga”), where researchers, endocrinologists, gastroenterologists, and previously trained nursing staff help with application of questionnaires,
obtaining blood samples and anthropometric measurements for each member of the participating families. The enrollment period lasted from September 2010 to September 2014.
Exclusion criteria were those families where one of its members suffered from a genetically
transmitted abnormality that could be clinically detected from their clinical history or laboratory tests such as: homozygous or heterozygous familial hypercholesterolemia, hyperchylomicronemia syndrome; hemoglobinopathies; Duchenne’s muscular dystrophy, hemophilia,
Huntington’s disease, Marfan syndrome, and phenylketonuria. In addition, pregnant women
were excluded due to metabolic changes present during this period, such as greater frequency
of GERD symptoms, which could be a potential confounder for the study results. Pregnant
women have the highest prevalence of GERD symptoms [29].

Data-collection instruments and data measurement
Questionnaires. Severity of GERD symptoms was assessed by the ReQuest in Practice
questionnaire consisting of six dimensions (general well-being, acidity complaints, lower
abdominal complaints, upper abdominal complaints, nausea, and sleep disturbances) using a
visual analog scale of 10 cms, referring to the severity of these symptoms in the last 24 hours.
This questionnaire was tried out in Germany, France, Spain, the United Kingdom, and the
United States [30,31], and has been translated into different languages to be applied in various
locations including Mexico [32,33]. In addition to this questionnaire, participants also filled
out a questionnaire of socio-demographic characteristics.
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Anthropometric and clinical measurements. Measurements for waist circumference
(WC), height and weight were taken were taken by previously trained research assistants. WC
was measured with a flexible tape at the mid-level between the lower lateral edge of the ribs
and the upper side of the iliac crest. This measurement was performed after a normal inhalation and exhalation recorded to the nearest 0.1 cm.
Systolic blood pressure (SBP) and the diastolic blood pressure (DBP) were recorded by a
single physician for all members of families, using a sphygmomanometer. The patients should
been have resting for 15 minutes before making three independent readings, recording the
average of the last two measurements for this study.
Biochemical estimations. In the morning, after an overnight fast of at least 8 hours, participants attended the hospital, where they had blood samples extracted for determination of
glucose level, high density lipoprotein cholesterol (HDL-C), triglycerides (TG), fibrinogen,
and C-reactive protein (CRP) in serum. To determine fasting plasma glucose, the analytical
method based on glucose oxidase reaction was used, which has a total coefficient of variation
(CV) of 4%. The determination of triglyceride concentration was performed using Trinder
enzymatic method, which a total CV of 4.5%. HDL cholesterol concentration was estimated by
the method for determining light absorption with a total CV of 4.5%. These biomarkers were
determined using LX-20 and LX-20-PRO equipment. Fibrinogen concentration was determined using the optical spectrophotometry technique, which has a total CV of 3.4%, with BCS
MAC equipment from Siemens, whilst the concentration of CRP was determined using the
nephelometry technique with the 800 IMMAGE equipment from Beckman, with a total CV of
7.5%. The determination of all these markers was undertaken in the central laboratory of the
General Hospital of Mexico “Dr. Eduardo Liceaga”.

Statistical analysis
Continuous variables are reported as the mean ± standard deviation (SD) for age, severity of
GERD symptoms (general well-being, acidity complaints, lower abdominal complaints, upper
abdominal complaints, nausea, sleep disturbances, and the total ReQuest score indicator
defined as the sum of all these symptoms), anthropometric measurements (WC and BMI),
metabolic syndrome components (SBP, DBP, concentration of fasting plasma glucose, TG,
and HDL-C), and inflammation markers (fibrinogen and CRP). We verified that the variables
did not have extreme outliers, that is, that the registers did not exceed the 4 standard deviations
in their values. Due to the existence of a sexual dimorphism, a comparison by sex of biochemical and anthropometric variables was performed using the Student’s t-test. For this test, variables for the severity of GERD symptoms were transformed by the square root function, while
inflammation and metabolic components were log10 transformed where necessary (as determined by the Shapiro-Wilk test). Dichotomous variable of diabetes mellitus (DM) (presence
or absence) was reported as the percentage of diabetic people in this population. This variable
was compared between men and women using a Pearson’s Chi-square test.
A factor analysis with previously transformed continuous variables was carried out using
principal components analysis and a varimax rotation in order to facilitate identification of the
variables within each of the factors. The number of factors was determined using the criterion
of eigenvalue greater than 1. Variables with loads greater than 0.4 were considered as part of a
factor in particular [34]. Statistical tests and factor analysis were performed using STATA software, version 13.0.
The variance-components model partitions the total phenotypic variance of the trait ðs2P Þ,
into components that correspond to additive genetic variance ðs2G Þ and unmeasured environmental variance including non-additive genetic components ðs2E Þ. Given the additive nature of
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the two components, the estimate of the heritability is given by h2 ¼ s2G =s2P . That is, the heritability refers to the proportion of phenotypic variance attributed to additive genetic variance. On
the other hand, the phenotypic correlation (ρP) between two phenotypes X and Y is given by
pffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffipffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
pffiffiffiffiffipffiffiffiffiffi
rP ¼ rG h2X h2Y þ rE ð1 h2X Þ ð1 h2Y Þ where ρG and ρE are the genetic correlation and
the environmental correlation, respectively. h2X and h2Y are the heritabilities of the phenotypes
pffiffiffiffiffiffiffi2ffiffi pffiffiffiffiffiffiffi2ffiffi
r r
ð1 hX Þ ð1 hY Þ
ffiffi2ffi
X and Y, respectively. Thus, the genetic correlation (ρG) is given by rG ¼ P E pffiffi2ffi p
,
hX

hY

which indicates the association grade between common genetic components. Genetic correlation is the proportion of the covariance of both phenotypes explained by common genetic components [35].
Heritability (h2) of quantitative traits, was calculated using a standard quantitative genetic
variance-components model by the maximum-likelihood method implemented in the Sequential Oligogenic Linkage Analysis Routines (SOLAR) software, version 7.2.5. Before estimating
the heritability and genetic correlation of quantitative traits, theses variables were transformed
by inverse normal transformation in SOLAR. The residual kurtosis was within normal range
after quantitative traits were transformed. The heritability of the diabetes mellitus variable
(dichotomous trait) was calculated by a threshold model in SOLAR. The method assumes that
an individual belongs to a specific effect status if an underlying genetically determined risk
exceeds a certain cut-off point [36]. Except for the heritability of WC and BMI, which were
only adjusted for age and sex, all the others phenotypes were adjusted for age, sex and BMI.
The estimation of the genetic correlation between the severity of GERD symptoms, MS components and inflammation components was performed with a maximum-likelihood bivariate
analysis in SOLAR to find an evidence of shared genetic (or pleiotropy) components, that is,
an evidence of additive effects of common genes on the traits. With the exception of the
genetic correlation where WC or BMI was involved, which were only adjusted for age and sex,
the rest of the genetic correlations were adjusted for the covariables of age, sex, and BMI. The
null hypothesis of no genetic effect (h2 = 0) was assessed. The rejection of h2 = 0 indicates additive genetic variance contribute to the phenotypic variance in a way statistically significant if pvalue is <0.05. Heritabilities (h2) of 0.25 or greater were considered as a significant contribution of the phenotypic variance attributed to additive genetic variance. Tests were performed
to test the null hypothesis that ρG = 0. The rejection of ρG = 0 indicates significant additive
effects of common genes on both traits. Evidence of a non-zero estimate for a given correlation
was considered statistically significant at p-value <0.05. Genetic correlations (ρG) of 0.2 or
greater, whose heritability (h2) in each of their two involved traits was 0.25 or greater, were
considered as a significant contribution of the covariance of both phenotypes explained by
common genetic components.

Ethics statement
This study was approved by the Ethics, Research and Biosecurity Committees from the General Hospital of Mexico “Dr. Eduardo Liceaga”. Each participant received and signed a written
informed consent.

Results
In this study, 32 extended families, resident in Mexico City were included, representing a total
of 585 individuals (249 men and 336 women) with a mean age of 41.5 ±16.7 years old. Family
size ranged between 13 and 32 individuals with a mean of 16 subjects. The characteristics of
age, severity of GERD symptoms, MS components, as well as inflammation components stratified by sex are shown in Table 1. Men showed statistically significant mean values higher than
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Table 1. Description of general data, severity of GERD symptoms, metabolic syndrome components and inflammation components by sex.
Variables

All, n = 585

Men, n = 249

Women, n = 336

p-valuea

Age (years)

41.5 (16.7)

39.3 (16.9)

43.1 (16.4)

0.006

General well-being of GERD

2.8 (2.2)

2.6 (2.2)

2.9 (2.2)

0.094

Acidity complaints

1.9 (2.3)

1.9 (2.3)

1.9 (2.4)

0.762

Upper abdominal complaints

2.0 (2.3)

1.8 (2.2)

2.2 (2.4)

0.104

Lower abdominal complaints

2.2 (2.5)

1.9 (2.4)

2.4 (2.6)

0.018

Nausea

1.2 (1.8)

1.1 (1.7)

1.2 (1.9)

0.483

Sleep disturbances

3.0 (3.1)

2.6 (2.9)

3.2 (3.2)

0.101

Total ReQuest score

13.0 (10.4)

12.0 (10.4)

13.8 (10.4)

0.018

Waist circumference (cm)

89.3 (13.7)

93.6 (13.7)

86.1 (12.8)

< 0.001

Body mass index (kg/m2)
Systolic blood pressure (mm Hg)

28.0 (6.1)

28.0 (6.2)

27.9 (5.9)

0.832

116.7 (17.1)

117.8 (14.5)

115.8 (18.7)

0.077
0.093

Diastolic blood pressure (mm Hg)

73.0 (10.4)

73.9 (10.4)

72.4 (10.4)

Fasting plasma glucose (mg/dl)

100.3 (39.3)

100.7 (42.9)

100.0 (36.4)

0.926

Triglycerides (mg/dl)

178.0 (117.9)

199.3 (129.8)

162.3 (105.8)

< 0.001

HDL-C (mg/dl)

42.3 (11.2)

37.6 (8.4)

45.7 (11.8)

< 0.001

Fibrinogen (mg/dl)

320.5 (83.0)

294.1 (74.6)

340.1 (83.6)

< 0.001

4.5 (4.6)

4.2 (4.8)

4.8 (4.5)

0.002

16.6

13.3

19.1

0.062b

C-reactive protein (mg/dl)
Diabetes mellitus (%)

Data for continuous variables are presented as means (SD). Diabetes mellitus is presented as percentage (%) of diabetics.
a

Student’s t-test was performed in all continuous variables. The GERD symptom variables were square root transformed, the metabolic syndrome
components and inflammation components were log10 transformed.

b

Pearson’s chi-square test was calculated.

GERD, gastroesophageal reflux disease; HDL-C, high-density lipoprotein-cholesterol.
https://doi.org/10.1371/journal.pone.0178815.t001

women in waist circumference (93.6 vs. 86.1 cm), triglycerides (199.3 vs. 162.3 ml/dl), while
women showed statistically significant higher mean values than men in age (39.3 vs. 43.1
years), lower abdominal complaints (1.9 vs. 2.4), total ReQuest score indicator (12.0 vs. 13.8),
HDL cholesterol (37.6 vs. 45.7 ml/dl), fibrinogen (294.1 vs. 340.1 mg/dl), and CRP (4.2 vs. 4.8
mg/dl). Regarding to the percentage of diabetics, women showed a prevalence of nearly six
percentage points higher than men (19.1 vs. 13.3, p-value = 0.062). No statistically significant
differences were found in the mean BMI according to the sex of the participants.
After adjusting by age, sex, and BMI, the heritability of the severity of GERD symptoms
ranged from 15% (p-value = 0.007) for upper abdominal complaints to 37% (p-value = 1.4 x
10−8) for sleep disturbances. Total ReQuest score had a heritability of 34% (p-value = 1.0 x
10−7). The continuous variables of the metabolic syndrome presented a heritability which
varied from 40% (p-value = 7.2 x 10−12) for concentration of fasting plasma glucose to 61%
(p-value = 7.2 x 10−26) for BMI. DM variable measured as a discrete variable had an h2 of 61%
(p-value = 1.1 x 10−5). Fibrinogen and CRP had an h2 of 64 (p-value = 1.0 x 10−22) and 38%
(p-value = 6.5 x 10−12), respectively. Except for the general well-being of GERD, upper abdominal complaints, and nausea, the remainder of the traits had a significant h2 greater than 25%
(Table 2).
Factors and factors loading are shown in Table 3. Four factors were extracted from the 14
continuous traits that were included in the analysis. The first factor (Factor I) explains 24.1%
of the total variance, was comprised of the six GERD symptoms from the ReQuest in Practice
questionnaire. The MS components were grouped into Factor II and Factor III, formed by
the systolic and diastolic blood pressure (14% of the total variance) and waist circumference,
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Table 2. Heritability estimates (h2) for the severity of GERD symptoms, metabolic syndrome components and inflammation components.
Traita

h2 (SE)

p-value

Variation explained by covariates

General well-being of GERD

0.24 (0.08)

4.0 x 10−5

-

Acidity complaintsb

0.27 (0.08)

2.5 x 10−6

-

Upper abdominal complaintsb

0.15 (0.07)

0.007

0.005

Lower abdominal complaintsb

0.27 (0.08)

7.3 x 10−6

0.009

Nausea

0.23 (0.07)

4.2 x 10−5

-

Sleep disturbancesb

0.37 (0.09)

1.4 x 10−8

-

Total ReQuest scoreb

0.34 (0.09)

1.0 x 10−7

0.009

Waist circumferencec

0.56 (0.08)

7.5 x 10−19

0.16

Body mass index

0.61 (0.07)

7.2 x 10−26

0.06

Systolic blood pressureb

0.43 (0.07)

3.5 x 10−16

0.23

Diastolic blood pressureb

0.50 (0.07)

2.0 x 10−23

0.14

Fasting plasma glucose

0.40 (0.07)

−12

7.2 x 10

0.17

Diabetes mellitusb,d

0.61 (0.16)

1.1 x 10−5

0.17e

Triglyceridesb

0.40 (0.08)

3.1 x 10−9

0.16

HDL-C

0.60 (0.08)

3.5 x 10−17

0.21

Fibrinogenb

0.64 (0.08)

1.0 x 10−22

0.18

C-reactive proteinb

0.38 (0.08)

6.5 x 10−12

0.18

b

b

c

b

b

a
b

All traits were treated as continuous except for diabetes mellitus.
Adjusted for age, sex and BMI.

c

Adjusted for age and sex.

d

Treated as discrete trait.
Variation explained by covariates as suggested by the Kullback-Leibler R-squared value.

e

GERD, gastroesophageal reflux disease; HDL-C, high-density lipoprotein-cholesterol.
https://doi.org/10.1371/journal.pone.0178815.t002

fasting plasma glucose, triglycerides and HDL (12.7% of the total variance), respectively. The
fourth factor (Factor IV) was formed by fibrinogen and CRP (12.3% of the total variance).
After adjusting for age and sex, the estimated heritability for the four factors was 31, 43, 53 and
48%, respectively (P-value < 1.0 x 10−6).
Table 4 shows the results of the analysis of genetic correlation between GERD symptoms,
MS components and inflammation markers. The correlations between the severity of the symptoms of GERD and MS components that were clinically relevant and statistically significant
were found between: acidity complaints and fasting plasma glucose (ρG = 0.40, p-value <0.05);
acidity complaints and DM (ρG = 0.49, p-value <0.05); sleep disturbances and fasting plasma
glucose ρG = 0.36, p-value <0.05), and between total ReQuest score and fasting plasma glucose
(ρG = 0.43, p-value <0.05). Statistically significant correlations between MS components and
inflammation markers were found between WC and fibrinogen (ρG = 0.42, p-value <0.01); WC
and CRP (ρG = 0.43, p-value <0.01); BMI and fibrinogen (ρG = 0.41, p-value <0.01); BMI and
CRP (ρG = 0.30, p-value <0.01), and between SBP and fibrinogen (ρG = 0.35, p-value <0.05).
Genetic correlation between fibrinogen and CRP was ρG = 0.42 (p-value <0.01). In all these correlations, the heritability of each of the two traits involved in the polygenic bivariate analysis
was greater than 25%.

Discussion
In this study, we estimated the heritability of the severity of GERD symptoms, MS components
and inflammation markers in a sample of Mexican families, finding that genetic components
significantly contribute to the familial segregation of these phenotypes. Regarding to the
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Table 3. Results of factor analysis, variance components and heritability estimation.
Factor I

Factor II

Factor III

Factor IV

(GERD symptoms)

(SBP/ DBP)

(WC/FPG/ TG/HDL-C)

(Fibrinogen/CRP

General well-being of GERD

0.663

-0.075

0.055

0.160

Acidity complaints

0.805

0.125

0.077

-0.017

Upper abdominal complaints

0.838

0.034

-0.085

-0.023

Lower abdominal complaints

0.823

0.020

-0.093

-0.012

Nausea

0.730

0.032

-0.009

0.012

Sleep disturbances

0.606

-0.070

0.077

0.083

WC

0.014

0.380

0.545

0.357

SBP

0.023

0.901

0.110

0.068

DBP

0.049

0.906

0.033

0.032

FPG

0.053

0.210

0.440

0.201

TG

-0.018

0.282

0.722

0.085

HDL-C

0.050

0.068

-0.837

0.081

Fibrinogen

-0.014

-0.020

-0.061

0.885

CRP

0.044

0.147

0.122

0.844

24.1

14.0

12.7

12.3

0.31 (0.08)*

0.43 (0.07)*

0.53 (0.08)*

0.48 (0.08)*

Factor loadings

Percentaje of variance (%)
Heritability, h2 (SE)

All traits were treated as continuous. The GERD symptom variables were square root transformed; metabolic syndrome components and inflammation
components were log10 transformed.
* Adjusted for age and sex. P-value < 1.0 x 10−6
GERD, gastroesophageal reflux disease; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglycerides; HDL-C,
high-density lipoprotein-cholesterol; FPG, fasting plasma glucose; CRP, C-reactive protein.
https://doi.org/10.1371/journal.pone.0178815.t003

severity of GERD symptoms, we found that acidity complaints, lower abdominal complaints,
sleep disturbances, and the total ReQuest score showed a significant heritability greater than
25%, while the lowest heritability for MS components was 40% for fasting plasma glucose, and
the highest was 61% for BMI and DM. Inflammation markers also showed a considerable heritability with 38% and 64% for CRP and fibrinogen, respectively. Concerning the genetic correlation analysis, we found that severity of some GERD symptoms share common genes with
some MS components such as acidity complaints with fasting plasma glucose (ρG = 0.40) and
with DM (ρG = 0.49); sleep disturbances with fasting plasma glucose (ρG = 0.36); and the total
ReQuest score with fasting plasma glucose (ρG = 0.43). With respect to MS components and
the inflammation markers we found that the traits which share common genes in these families are: fibrinogen with WC (ρG = 0.42); fibrinogen with BMI (ρG = 0.41); fibrinogen with systolic blood pressure (ρG = 0.35); CRP with WC (ρG = 0.43), and CRP with BMI (ρG = 0.30).
Regarding to the inflammation markers, we found that fibrinogen and CRP also share common genes ρG = 0.42).
Previous studies in twins have shown an importance of genetic effects for the GERD development, finding a heritability of 43 [21] and 31% [22]. In this study, we also found considerable genetic effects for the severity of GERD symptoms: for total ReQuest score the heritability
was 34%. The difference, mainly with the first study, could be because they analyzed the presence of GERD, while we only analyzed the severity of symptoms, in addition, the design of
early studies was focused on twins, while we used a family-based design. Due to the fact that
several studies [10] have found a positive association between GERD and an increase in BMI,
in this study, the heritability was adjusted for age, sex, and BMI, finding that this last variable
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Table 4. Genetic correlationa between severity of GERD symptoms, inflammation components and metabolic syndrome components.
WCb

BMIb

SBP

DBP

FPG

DM

TG

HDL-C

Fibrinogen

CRP

0.26 (0.17)

0.21 (0.17)

0.23 (0.19)

0.30
(0.16)

0.39
(0.21)

0.62
(0.27)*

0.04
(0.22)

0.03
(0.19)

0.31 (0.16)

0.25 (0.19)

Acidity complaints

−0.003
(0.17)

−0.09 (0.16)

0.07 (0.18)

0.06
(0.16)

0.40
(0.19)*

0.49
(0.21)*

0.27
(0.20)

−0.08
(0.18)

0.21 (0.16)

0.13 (0.18)

Upper abdominal
complaints

−0.18 (0.22)

−0.24 (0.20)

−0.11 (0.22)

0.02
(0.20)

0.48
(0.27)

0.37
(0.33)

0.12
(0.27)

0.001
(0.23)

0.04 (0.21)

0.13 (0.23)

Lower abdominal
complaints

0.04 (0.17)

−0.04 (0.16)

−0.004
(0.18)

0.13
(0.16)

0.25
(0.18)

−0.17
(0.22)

−0.13
(0.19)

0.17
(0.18)

−0.22
(0.17)

−0.07 (0.19)

Nausea

−0.13 (0.18)

−0.15 (0.16)

0.01 (0.18)

0.02
(0.16)

0.28
(0.19)

0.01
(0.23)

0.27
(0.21)

0.13
(0.18)

−0.28
(0.18)

−0.04 (0.19)

Sleep disturbances

0.002 (0.16)

0.06 (0.14)

−0.01 (0.16)

−0.05
(0.14)

0.36
(0.17)*

0.23
(0.21)

−0.07
(0.18)

−0.02
(0.16)

−0.12
(0.15)

−0.01 (0.17)

Total ReQuest score

0.02 (0.16)

0.003 (0.15)

0.06 (0.16)

0.09
(0.15)

0.43
(0.18)*

0.33
(0.23)

0.08
(0.19)

−0.04
(0.17)

0.02 (0.16)

0.04 (0.18)

Fibrinogen

0.42 (0.11)** 0.41 (0.11)** 0.35 (0.14)*

0.16
(0.14)

−0.20
(0.15)

0.03
(0.20)

0.28
(0.16)

−0.05
(0.15)

-

0.42 (0.11)**

CRP

0.43 (0.12)** 0.30 (0.11)**

−0.15
(0.12)

0.02
(0.13)

−0.01
(0.16)

0.15
(0.15)

0.12
(0.12)

-

-

General well-being of
GERD

−0.001
(0.13)

Data are presented as ρG(SE).
All genetic correlations were adjusted for age, sex & BMI except for those that involved WC or BMI.

a
b

The genetic correlation between WC or BMI and another trait was adjusted for age and sex.

* significant genetic correlation at *p < 0.05
** significant genetic correlation **p < 0.01.
GERD, gastroesophageal reflux disease; WC, waist circumference; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure;
FPG, fasting plasma glucose; DM, diabetes mellitus; TG, triglycerides; HDL-C, high-density lipoprotein-cholesterol; CRP, C-reactive protein.
https://doi.org/10.1371/journal.pone.0178815.t004

was not statistically significant in the analysis of the severity of any symptoms, ie, the heritability of the severity of GERD symptoms was not affected by BMI.
Regarding MS components, the heritabilities of continuous traits in this study are in the
range of the reported heritabilities in other studies; 37–59% for WC, 16–61% for systolic blood
pressure, 12–61% for diastolic blood pressure, 15–59% for fasting plasma glucose, 17–47% for
triglycerides, and 54–72% for HDL-C [23,24,26,27]. These differences in heritabilities could be
related to the diversity of genetic backgrounds or the level of environmental effects in the population. Moreover, the discrepancy may also be attributed to the variation in the composition
of study populations, different sample sizes, covariables included in the analyses, and whether
the study is conducted in twins or families. The study by Sung et al. [27], based on a study of
twins, show the highest heritabilities because twin studies are more likely to show higher heritability estimates compared with those made in family studies [37].
In factor analysis, four clearly differentiated factors were found. Factor 1, was formed of the
six GERD symptoms, which was expected due to the construction of the questionnaire
ReQuest in Practice [30,31], used to measure the severity of GERD symptoms. The heritability
of this component was 31%. The MS components were grouped into two factors: Factor II
which was formed of SBP and DBP, and Factor III composed of WC, fasting plasma glucose,
triglycerides, and HDL-C. This clustering of metabolic syndrome components coincides with
that reported by Lin et al. [24] about how factors are formed. Nevertheless, there were differences in the reporting of heritability of them, whereas in our study we found that it was 43 and
53% for Factor II and Factor III, respectively, in the study of Lin et al. the heritability was 20
and 44%. In addition to genetic and environmental background, this difference could be due

PLOS ONE | https://doi.org/10.1371/journal.pone.0178815 June 5, 2017

9 / 13

Heritability of GERD symptoms severity in Mexican families

to the formation of pedigrees because in this last study, the family size varied from 3 to 53
members, with an average of 9, while in our study, the formation of pedigrees was more homogeneous with family sizes ranging from 13 to 32 members, with a mean of 16. In another study
conducted by Sung et al. [27], MS components were also grouped into two factors, but these
were formed of lipids and waist circumference for the first factor, and fasting plasma glucose,
mean of blood pressure and waist circumference for the second factor. Heritability for these
factors was 63 and 60%, respectively. These differences, regarding the findings in our study
could be due to Sung et al. study Korean population and the design of their study is based on
twins. Finally, our Factor IV was formed exclusively of inflammation markers (fibrinogen and
CRP), whose heritability was 48%, suggesting that the variability of inflammation components
is significantly explained by genetic factors.
The bivariate analysis of polygenic equations shows that the severity of the symptom of
acidity shares common genes with the presence of an increased level of fasting plasma glucose
and with the presence of DM (ρG = 0.40 and ρG = 0.49, respectively). These genetic correlations
could explain the phenotypic associations found in other studies, such as the association
between hyperglycemia and esophagitis for reflux [16], as well as the presence of DM and
abnormal gastroesophageal reflux [20]. That is, these phenotypic associations could be
explained in large part to the coexistence of common genetic components between these traits.
Sleep disturbances and the total ReQuest score also showed a statistically significant genetic
correlation with the increasing of fasting plasma glucose. We did not find relevant and statistically significant genetic correlations between the severity of the other GERD symptoms and
the other MS components. On the other hand, the statistically significant genetic correlations
that we found between the inflammation markers (fibrinogen and CRP), and waist circumference and BMI confirm the strong relationship already established in the literature between
these traits, in this case, from the point of view of common genetic components.
One of the limitations that might be pointed out for this study is that we analyzed general
or relatively healthy population in terms of the presence of gastroesophageal reflux disease,
that is, no proband was considered to determine the presence or absence of this disease. However, it is worth to emphasizing that the aim of this study was to analyze the heritability of the
severity of GERD symptoms, not the presence or absence of this pathology. In other words,
regardless of the degree of severity of these symptoms, if these are considerably explained by
genetic components, it would be expected that, on the whole, the subjects present similar
degrees of severity to the rest of the members inside of each family. In this sense, the use of the
ReQuest in Practice questionnaire was quite useful due to its quantitative measurement, allowing the estimation of heritability of the severity of GERD symptoms as quantitative traits
whose maximization in the heritability analysis is faster and more reliable than the analysis of
discrete traits [38]. A strength of this study is the inclusion of extended families, which provide
greater statistical efficiency than any other design (nuclear families or twins) for determining
heritability, requiring a smaller sample than the other designs [39,40].
In conclusion, in this study we demonstrated that the severity of some GERD symptoms,
MS components, and inflammation markers are considerably explained by genetic factors in
Mexican families. Statistically significant genetic correlations between the severity of some of
GERD symptoms and fasting plasma glucose suggest that the association of genetic components between the severity of GERD symptoms and the metabolic syndrome might be mediated by genetic components involved in the level of plasma glucose concentration. These
findings provide evidence that justifies conducting further investigation, as the determination
of a linkage analysis in order to identify regions of susceptibility for developing of GERD and
metabolic syndrome.
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